Clinical Trials Logo

Recurrent Thymoma and Thymic Carcinoma clinical trials

View clinical trials related to Recurrent Thymoma and Thymic Carcinoma.

Filter by:
  • None
  • Page 1

NCT ID: NCT00718809 Terminated - Clinical trials for Recurrent Thymoma and Thymic Carcinoma

Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer

Start date: June 2008
Phase: Phase 2
Study type: Interventional

This phase II trial is studying how well saracatinib works in treating patients with relapsed or refractory thymoma or thymic cancer. Saracatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth